Takeda Pharmaceutical (TAK) EBIT Margin (2017 - 2026)
Takeda Pharmaceutical (TAK) recorded EBIT Margin of 16.51% in the quarter ended Jun 30, 2026, down 0.17 percentage points from 16.68% a year earlier and unchanged from the prior quarter.
Takeda Pharmaceutical (TAK) EBIT Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Takeda Pharmaceutical's EBIT Margin came in at 5.83% as of Jun 30, 2026, down 4.55 percentage points year-over-year; for the year ended Mar 31, 2026, it came in at 0.14%, down 7.34 percentage points from the prior year.
- Annual EBIT Margin has a five-year change of -15.79 percentage points (years ended Mar 2021 to Mar 2026).
- Across earlier years, EBIT Margin came in at 7.48% in the year ended Mar 31, 2025 (+2.46 pp), 5.02% in the year ended Mar 31, 2024 (-7.16 pp), 12.18% in the year ended Mar 31, 2023 (-0.73 pp) and 12.91% in the year ended Mar 31, 2022 (-3.01 pp).
- Quarterly EBIT Margin has ranged from -38.03% in the quarter ended Dec 31, 2025 to 25.56% in the quarter ended Mar 31, 2022 over the past five years.
- On a year-over-year basis, EBIT Margin rose in four of the last eight quarters, with an average year-over-year change of -5.21 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 2.91 percentage points in the quarter ended Jun 30, 2025, against a drop of 30.92 percentage points in the quarter ended Dec 31, 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 16.51% (quarter ended Mar 31, 2026), -38.03% (quarter ended Dec 31, 2025) and 11.97% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Takeda Pharmaceutical | 2.74 Bn | -23.77 Bn | 5.10 Bn | 16.51% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.51% |
| Mar 31, 2026 | 16.51% |
| Dec 31, 2025 | -38.03% |
| Sep 30, 2025 | 11.97% |
| Jun 30, 2025 | 16.68% |
| Mar 31, 2025 | 15.28% |
| Dec 31, 2024 | -7.11% |
| Sep 30, 2024 | 11.83% |
| Jun 30, 2024 | 13.77% |
| Mar 31, 2024 | 13.96% |
| Dec 31, 2023 | 8.43% |
| Sep 30, 2023 | 12.51% |
| Jun 30, 2023 | 15.92% |
| Mar 31, 2023 | 15.93% |
| Dec 31, 2022 | 13.40% |
| Sep 30, 2022 | 10.42% |
| Jun 30, 2022 | 15.48% |
| Mar 31, 2022 | 25.56% |
| Jun 30, 2021 | 26.17% |
| Mar 31, 2021 | 32.27% |
Takeda Pharmaceutical EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();